Timothy Boyd Roberson, PA-C

Timothy Roberson practices at Genetic Technological Innovations in Scottsdale, Arizona.

Timothy Roberson's NPI, 1194059071, was assigned on September 25, 2009. Timothy Roberson holds Texas license PA06374.

Timothy Roberson's primary practice is Genetic Technological Innovations, at 14500 N Northsight Blvd, Scottsdale, AZ 85260 in Maricopa County. The practice phone is (480) 674-6565.

Timothy Roberson's primary practice is Genetic Technological Innovations in Scottsdale, Arizona. The medical group on file is Wound Management Specialists. Dmand AI also links Timothy Roberson to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Timothy Roberson practices. Vendor and product names are available with a free account.

Physician assistant is Timothy Roberson's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Timothy Roberson is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Timothy Roberson is licensed in Texas.

Dmand AI lists arteritis, arthritis, drug use disorders, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain and lower back pain among the conditions Timothy Roberson treats.

CMS data shows 1,798 Medicare services from Timothy Roberson across 4 procedure codes in 2024, for 275 Medicare patients. Medicare paid $31,540 for them. Every service was in an office.

CMS counts 275 Medicare patients who saw Timothy Roberson in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have arthritis, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Timothy Roberson's median patient age at 82, with 62% women.

In 2024, Timothy Roberson wrote 2,715 Medicare Part D claims for 590 patients. 94% of them were for generic drugs. CMS names the drug for 2,560 of them, across 29 drugs with 11 or more claims each, at $681,312 in total drug cost.

Timothy Roberson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 164 general payments to Timothy Roberson from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $712.